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Metabolic Acidosis Increases Intracellular Calcium in Bone Cells
Through Activation of the Proton Receptor OGR1
Kevin K Frick, Nancy S Krieger, Keith Nehrke, and David A Bushinsky
ABSTRACT: Metabolic acidosis increases urine Ca without increasing intestinal absorption, leading to bone
Ca loss. It is unclear how bone cells detect the increase in proton concentration. To determine which G
protein–coupled proton sensing receptors are expressed in bone, PCR was performed, and products were
detected for OGR1, TDAG8, G2A, and GPR4. We tested the hypothesis that the G protein–coupled proton
sensor, OGR1, is an H
+-sensing receptor in bone. To determine whether acid-induced bone resorption
involves OGR1, we incubated mouse calvariae in neutral pH (NTL) or acidic (MET) medium ± the OGR1
inhibitor CuCl2. CuCl2 decreased MET-induced Ca efﬂux. We used ﬂuorescent imaging of perfused bone
cells to determine whether MET increases Cai. Perfusion with MET induced a rapid, ﬂow-independent,
increase in Cai in individual bone cells. To determine whether transfection of OGR1 into a heterologous cell
type would increase Cai in response to H
+, we perfused Chinese hamster ovary (CHO) cells transfected with
mouse OGR1 cDNA. Perfusion with MET induced a rapid increase in Cai in OGR1-transfected CHO cells.
These data indicate that OGR1 induces an increase in Cai in response to MET and is a prime candidate for an
osteoblast proton sensor.
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INTRODUCTION
C
HRONIC METABOLIC ACIDOSIS alters calcium (Ca) ho-
meostasis by increasing urine Ca excretion without a
corresponding increase in intestinal Ca absorption, leading
to depletion of the primary Ca reservoir in the body, the
skeleton.
(1,2) In vivo, mild metabolic acidosis, induced by
ample dietary protein intake and an age-related decline in
acid excretion, may deplete bone Ca stores.
(1–3) This pro-
cess can be modeled in vitro by culturing neonatal mouse
bone in physiologically acidic medium.
(4) We have found
that, in the earliest time periods (24 h), bone calcium
efﬂux is directly related to the magnitude of the fall in pH
and caused by non–cell-mediated physicochemical mineral
dissolution.
(5,6) In contrast, at later time periods (>24 h),
the continued calcium efﬂux is caused by cell-mediated
bone resorption.
(7–10) Metabolic acidosis regulates both
osteoblastic and osteoclastic activity. Acidosis decreases
expression of osteoblastic extracellular matrix proteins,
including type 1 collagen,
(7,8) osteopontin, and matrix gla
protein,
(11,12) and increases expression of COX-2
(10) and
RANKL.
(9,13) Acidosis also increases secretion of osteo-
clastic b-glucuronidase.
(8)
How the bone cells sense the changes in extracellular
pH (proton concentration, [H
+]) is not clear. Various
families of acid-sensitive ion channels including the ASICs,
TRPV1, and TASK are known to be expressed in pain
sensing,
(14) skeletal muscle,
(15) and taste cells.
(16,17) In ad-
dition, there is a family of G protein–coupled proton-
sensing receptors.
(18) This small family (40–50% shared
homology) of G protein–coupled receptors includes the
ovarian cancer G protein–coupled receptor 1, OGR1 (also
called GPR68),
(19) GPR4,
(19) T-cell death–associated gene
8 (TDAG8, also called GPR65),
(20,21) and G2A (also called
GPR132).
(21,22) These receptors are coupled either to
phosphoinositide metabolism and increased Cai (OGR1
and G2A)
(19,22) or alteration in adenylate cyclase activity
(GPR4 and TDAG8).
(19–21) Ludwig et al.
(19) reported that
OGR1 is expressed in mouse osteoblasts and that reduc-
tion in pH (increases in [H
+]) leads to an accumulation of
phosphoinositide metabolites, making OGR1 a prime
candidate for an osteoblastic proton sensor.
To test the hypothesis that OGR1 acts as an H
+-sensing
receptor in bone cells, we studied whether an inhibitor of
OGR1 (CuCl2) would diminish acidosis-induced Ca efﬂux
from bone, whether metabolic acidosis would increase Cai
in cultured bone cells, and whether transfection of OGR1
into a heterologous cell type would permit cells to mimic
the Cai response to acidosis of primary bone cells. We
found that CuCl2 inhibits the acidosis-induced increase in
Ca efﬂux from bone cells and that primary murine calvarial
bone cells respond to a decrease in extracellular pH with
an increase in Cai. We found that Chinese hamster ovary
ﬁbroblasts (CHO cells) transfected with murine OGR1
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305cDNA now respond to acidosis with increased Cai. These
data are consistent with a primary role for OGR1 as a
sensor for H
+ in bone cells.
MATERIALS AND METHODS
Reagents
All reagents, unless otherwise speciﬁed, were obtained
from Sigma-Aldrich (St Louis, MO, USA).
Animals and cells
CD-1 mice were obtained from Charles River (Wilmington,
MA, USA). CHO ﬁbroblasts were a gift from Patricia
Hinkle (University of Rochester, Rochester, NY, USA)
and grown in aMEM (Invitrogen, Carlsbad, CA, USA)
containing 5% heat-inactivated fetal bovine serum (FBS;
Invitrogen) and penicillin (100 U/ml; Sigma-Aldrich).
RNA isolation and PCR
RNA was isolated from primary calvarial cells using a
Qiagen RNeasy kit (Valencia, CA, USA) as previously
described.
(9) Total RNA (1 mg) was reverse transcribed to
ﬁrst-strand cDNA using an iScript cDNA synthesis kit
(Biorad, Hercules, CA, USA) and ampliﬁed by PCR using
iQ SYBR-green in an iCycler thermocycler (Biorad).
PCR primers were synthesized by Integrated DNA
Technologies (Coralville, IA, USA) and were as follows:
OGR1 (forward, 59-CCTCAACCTGTTTCGGACGTGC;
reverse, 59-CCACATATCAGCTCTCCCCGTCTC); G2A
(forward, 59-GACATGGATGCCGTGTGTGCC; reverse,
59-CCCAGACGGTGACTCAGAGGAC); GPR4 (for-
ward, 59- ACCGAGCGCCAGGAGAAAGTC; reverse,
59-GGAGGCACTGCCCAGACAGC); and TDAG8( f o r -
ward, 59-CCTCAACCTGTTTCGGACGTGC; reverse,
59-CCACATATCAGCTCTCCCCGTCTC). PCR products
wereresolvedbyelectrophoresisinagarose(Invitrogen)and
migration rate compared with a size standard (1 kb Plus
DNA Ladder; Invitrogen).
Effect of CuCl2 on bone calcium efﬂux
Calvariae from 4- to 6-day-old CD-1 mice were dissected
and incubated in 2.8 ml DMEM (Lonza, Walkersville, MD,
USA) containing 15% heat-inactivated horse serum
(Invitrogen), heparin (10 USP units/ml; Baxter Healthcare,
Deerﬁeld, IL, USA), and penicillin (100 U/ml) in 35-mm
dishes at neutral pH (NTL, pH ’ 7.4) or at a physiologi-
cally acidic pH (MET, pH ’ 7.1) produced by a primary
reduction in [HCO3
2], as a model of metabolic acido-
sis.
(6,8,23) Calvariae were incubated in NTL or MET each
without or with 100 mM CuCl2 for a total of 48 h. Imme-
diately before adding two bones per dish on a square, 9-cm
2
stainless steel mesh grid supported on 0.5-cm legs, 1 ml of
medium was removed to determine preincubation pH,
PCO2 and [Ca]. At the conclusion of the ﬁrst 24-h incu-
bation period, medium was removed, analyzed for pH,
PCO2, and [Ca], and replaced with similar, fresh pre-
incubated medium. At the conclusion of the second 24-h
incubation period, medium was again analyzed for pH,
PCO2, and [Ca]. Throughout all experiments, the PCO2
was maintained at the physiologic normal of ’40 mmHg.
To closely replicate physiological conditions, only the
HCO3
2/CO2 buffer system was used; no other buffers were
added to the medium. All medium was preincubated at
PCO2 ’40 mmHg, 378C, for at least 3 h before use. The
number of pairs of bones chosen in each group was de-
termined by power analysis using actual means and SD
from initial experiments with an n = 4. We assumed
probability of a type I error (a) = 0.05 and the probability
of a type II error (b) = 0.10. We used Statistica (version 6.0;
StatSoft, Tulsa, OK, USA). For a statistical power (1 2 b)
goal of 0.9, we needed eight pairs of bones in each group. In
the protocols above, we used 10–12 pairs of bones in each
group.
Primary bone cell culture
Primary bone cells, which are almost exclusively osteo-
blasts,
(24) were isolated from neonatal CD-1 mouse calvar-
iae immediately after dissection as described previ-
ously.
(24,25) Brieﬂy, bones were washed in PBS containing
4 mM EDTA for 10 min at 378C and incubated in HEPES
(25 mM), pH = 7.4, containing 2 mg/ml collagenase (Wako
Pure Chemicals, Dallas, TX, USA) and 90 mMN a-tosyl-L-
lysyl chloromethyl ketone for three sequential 20-min di-
gestion periods at 378C in a shaking water bath. At the end
of each digestion, released cells were collected and re-
suspended in HEPES buffer containing 1 mM MgSO4, and
all three digests were pooled in DMEM (Lonza, Walkers-
ville, MD, USA) containing 15% heat-inactivated horse
serum (Invitrogen), heparin (10 USP units/ml; Baxter), and
penicillin (100 U/ml) for plating on 8-mm glass coverslips
(Warner Instruments, Hamden, CT, USA). Coverslips were
used for imaging 1–5 days after initial plating.
Cell imaging
To reduce background, DMEM without phenol red
(Invitrogen) was used for perfusion while imaging. To
closely replicate physiological conditions, only the HCO3
2/
CO2 buffer system was used; no other buffers were added to
the medium. The acidity of the medium was adjusted by a
primary reduction in [HCO3
2] as a model of metabolic ac-
idosis as previously reported.
(6,8,23) The partial pressure of
medium CO2 (PCO2) was maintained by gentle bubbling
with 5% CO2 in air (AirGas, Rochester, NY, USA) for at
least 15 min before perfusion. A continuous ﬂow of equili-
brated mediumwasestablishedthroughanopenmicroscope
chamber (RC-26; Warner Instruments; ;200-mlv o l u m e )b y
use of a peristaltic pump (;1 ml/min) and aspiration. To
reduce gas loss, where possible, Viton (DuPont, Wilming-
ton, DE, USA) or ﬂuorinated ethylene-propylene (FEP)
tubing was used. Flow control was accomplished with a
manually operated perfusion valve system (V-6; Warner
Instruments). To load cells on coverslips with fura-PE3
(TefLabs, Austin, TX, USA), coverslips were washed with
ice-cold PBS and incubated for 45 min at 378Ci nD M E M
containing 4.4 mM fura-PE3 and 48 mM pluronic acid F127
(Invitrogen). Coverslips were mounted in the chamber
with ﬂow of neutral medium. For stimulation with acidic
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switched attime=0 toacidic medium.The chamberbecame
acidiﬁed at ;180 s as determined in a subset of experiments
(n = 36), using a pH electrode in the chamber (Thermo,
Beverly, MA, USA). Cells were visualized with a Nikon
Eclipse 2000U inverted microscope (320 objective; Nikon,
Tokyo, Japan) equipped with a CCD camera (Cooke,
Romulus,MI, USA). Each ﬁeld wasimaged every2 s for 600 s.
Intracellular Ca (Cai) levels were measured from ﬂuo-
rescentemissions at510nmafterexcitation at340 and380 nm
using a dual wavelength excitation system (TILL Pho-
tonics, Munich, Germany). Fluorescence data were in-
terpreted and analyzed with TILLVision software (TILL
Photonics). As calculations of absolute Cai require many
assumptions and remain estimates, ratios of 340 nm/380 nm
were used in this study and reported as relative ﬂuorescence
intensity.
(26,27) The maximum peak to nadir ratio for each
cell was recorded and used to construct the summary graphs
(Figs. 4A and 6A).
pH, PCO2, and total calcium measurements
Medium was sampled with a syringe, and pH and PCO2
were determined with a blood-gas analyzer (ABL5; Radi-
ometer, Copenhagen, Denmark), and the concentration of
medium bicarbonate ([HCO3
2]) was calculated from pH
and PCO2 as described previously.
(6,28) Ca was measured
by an ion selective electrode (Model 10; Nova Biomedical,
Waltham, MA, USA).
Stable transfection of CHO cells
A full-length cDNA for murine OGR1 was recovered
from calvarial cell RNA by standard techniques
(29,30) and
inserted into the mammalian expression vector pcDNA3.1/
V5-His-TOPO (Invitrogen). The identity of the insert was
conﬁrmed by sequencing. Plasmid DNA was transfected
into CHO cells with Lipofectamine LTX as directed by
manufacturer (Invitrogen). Stable transfectants were se-
lected for growth in medium containing 420 mg/ml G418
(Invitrogen). The V5 epitope tag was used to screen for
mOGR1 expression; transfectants selected for further
study had ;30% V5 + cells after staining with antiserum to
V5 (Invitrogen).
Statistical analyses
All values were expressed as mean ± SE. Tests of sig-
niﬁcance were calculated using Student’s t-test, ANOVA
with Bonferroni correction for multiple comparisons
(means), or the Kolmogorov–Smirnov test (distributions)
using conventional programs (Statistica; StatSoft, Tulsa,
OK, USA) on a personal computer. p < 0.05 was consid-
ered signiﬁcant.
RESULTS
Expression of H
+-sensing receptors in bone cells
To determine the pattern of expression of the four known
G protein–coupled proton sensing receptors (OGR1, G2A,
GPR4, and TDAG8) in bone cells isolated from mouse
calvariae, RNA was isolated and reverse transcribed and
PCR was performed with speciﬁc primers (see the Materials
and Methods section). We found that each of the four
known proton receptors was present in the cultured bone
cell RNA (Fig. 1). Whereas G2A expression appears less
abundant than the other three isoforms, the image shows
plateau levels, and absolute abundance was not determined.
Effect of CuCl2 on bone resorption
Totest the hypothesis that the initial step inacid-induced
bone resorption involves signal transduction through
OGR1, we incubated neonatal mouse calvariae in the ab-
sence or presence of the OGR1 inhibitor CuCl2 (100
mM).
(19) CuCl2 has been shown to inhibit OGR1 through
essential histidine residues.
(19) Incubation of calvariae with
physiologically acidic medium (MET, pH = 7.17 ± 0.02,
PCO2 = 36.4 ± 0.9 mmHg, [HCO3
2] = 12.9 ± 0.5 mM) led to
a signiﬁcant increase in net Ca efﬂux compared with in-
cubation in neutral pH medium (NTL, pH = 7.45 ± 0.01,
PCO2 = 35.8 ± 0.3 mmHg, [HCO3
2] = 24.6 ± 0.2 mM;
Fig. 2). Incubation of calvariae with physiologically neu-
tral medium in the presence of CuCl2 (pH = 7.46 ± 0.02,
PCO2 = 34.9 ± 1.1 mmHg, [HCO3
2] = 24.4 ± 0.2 mM) led to
a signiﬁcant decrease in net Ca efﬂux compared with in-
cubation in neutral pH medium in the absence of CuCl2.
Incubation of calvariae with MET + CuCl2 (pH = 7.19 ±
0.03, PCO2 = 35.0 ± 0.8 mmHg, [HCO3
2] = 12.9 ± 0.4 mM)
signiﬁcantly inhibited acid-induced Ca efﬂux and was not
different from calvariae incubated in NTL + CuCl2 me-
dium, consistent with the hypothesis that OGR1 activation
is necessary for acid-induced bone Ca efﬂux.
Measurement of Cai in primary bone cells
Because OGR1 has been shown to be coupled to
phospholipase C, leading to increased IP3 production and
subsequent increases in intracellular Ca (Cai), we next
determined whether Cai was altered in response to a
physiologic reduction in pH. Changes in Cai were mea-
sured by loading primary bone cells with Fura-PE3 and
FIG. 1. Expression of H
+-sensing receptors
inbonecells. RNAwas isolatedfromprimary
calvarial cells, reverse transcribed, and am-
pliﬁed by PCR using primer sequences. PCR
products were resolved by electrophoresis
and migration rate compared with a size
standard.
ACIDOSIS INCREASES INTRACELLULAR CA THROUGH OGR1 307measuring the ratio of ﬂuorescent emissions at 510 nm
after excitation at 340 and 380 nm. The bone cells were
continuously perfused with neutral (NTL, pH = 7.40,
PCO2 = 47 mmHg, [HCO3
2] = 29 mM) medium, which did
not lead to a signiﬁcant alteration of Cai (Fig. 3A).
Cells were perfused with NTL followed by MET. Again,
perfusion of the cells with NTL (pH = 7.42 ± 0.02, PCO2 =
44.4 ± 1.2 mmHg, [HCO3
2] = 28.2± 1.0 mM) did notchange
Cai (Fig. 3B, 0–180 s). In contrast, when the cells were
perfused with MET (pH = 6.90 ± 0.03, PCO2 =4 1 . 8±1 . 7
mmHg, [HCO3
2] = 8.2 ± 0.8 mM), there was a substantial,
rapid increase in Cai in multiple cells (Fig. 3B, 182–600 s).
The increase in Cai in response to MET was asynchronous,
occurred in individual cells at various times after the initial
exposure to MET, and varied in magnitude and duration. A
pseudocolor representation of selected ﬁelds among those
analyzed for Fig.3B is showninFig. 3C. Theﬁrst frame(C1)
indicates the initial time (time = 0 s), and the latter three
frames show representative responses to acidiﬁcation at 198,
221, and 288 s for C2, C3, and C4, respectively. Arrows
indicate cells whose relative ﬂuorescence intensity is shown
inthe correspondingtraces inD1–D4. Cells shown in C1–C4
and corresponding traces D1–D4 show various patterns of
response, with some cells displaying single peaks, whereas
others exhibit more complex responses.
Changes in Cai were quantiﬁed by two methods: the
distribution of cell number by the peak to nadir ratio and
the percentage of cells with an increase in Cai above spe-
ciﬁc threshold values.
The ratio of the maximum to minimum Cai for each cell
during the initial NTL and MET phases of perfusion was
determined for all 300 time points for each cell and the
distribution of values plotted. The distribution of the peak
to nadir ratio for cells during the MET phase of perfusion
was signiﬁcantly different than that for the NTL phase of
perfusion with more cells in MET having a greater peak to
nadir ratio (n = 2306 cells in each group; Fig. 4A) and the
mean value of the ratio (inset) was signiﬁcantly increased
with MET.
The percentage of cells with an increase in Cai above a
speciﬁc threshold (1.1) was determined. A peak in cell Cai
was deﬁned as a >1.1 increase in area under the curve of
Cai for each 2-s time interval compared with the mean area
under the curve for the previous ﬁve time intervals for that
cell. This calculation was repeated for threshold values of
1.2, 1.3, 1.4, and 1.5. Compared with the initial NTL phase
of imaging, there was a signiﬁcant increase in the per-
centage of cells with Cai peaks >1.1, >1.2, >1.3, and >1.4
during the MET phase of imaging (n = 2306 cells individ-
ually analyzed; Fig. 4B).
Measurement of Cai in OGR1-transfected CHO cells
We next tested the hypothesis that expression of OGR1
in CHO cells would lead to a MET-induced increase in Cai.
Nontransfected CHO cells do not increase Cai in response
to MET (pH = 7.02, PCO2 = 52 mmHg, [HCO3
2] = 13 mM)
compared with NTL (pH = 7.37, PCO2 = 51 mmHg,
FIG. 2. Effect of CuCl2 on bone Ca efﬂux. Calvariae from CD-
1 mice were incubated in physiologically neutral (NTL) or acidic
(MET) medium for 48 h in the absence or presence of 100 mM
CuCl2 with a medium change at 24 h. Results are the mean ± SE
for 10–12 pairs of calvariae in each group. *Different from NTL,
p < 0.05;
+different from MET, p < 0.05.
FIG. 3. Imaging of Cai in primary bone
cells. Primary bone cells on coverslips were
loaded with fura-PE3 and perfused with
physiologically neutral (NTL) or acidic
(MET) medium. Cai levels were determined
from ﬂuorescent emissions at 510 nm after
excitation at 340 and 380 nm using a dual
wavelength excitation system. (A) Perfusion
with NTL only. (B) Perfusion with NTL (0–
180 s) followed by MET (182–600 s). Arrow,
time of chamber acidiﬁcation. Relative ﬂuo-
rescence as a function of time for all cells is
shown in C (n = 79 individual cells). (C)
Pseudocolor images of relative ﬂuorescence
intensity; C1, time = 0; C2, time = 198 s; C3,
time = 221 s; C4, time = 288 s Arrows indicate
selected cells whose change in ﬂuorescence
as a function of time is shown in D1–D4,
respectively.
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Fig. 3 is 4/C[HCO3
2] = 29 mM; n = 1234 cells in each group, % cells
with peaks >1.2: NTL = 4.1 ± 2 versus MET = 2.7 ± 0.7, p =
not signiﬁcant; data not shown).
CHO cells were transfected with a plasmid encoding full-
length mouse OGR1 cDNA and selected for antibiotic
resistance. Stable lines were screened for expression of a
V5 epitope encoded by the expression plasmid; up to
;30% of cells were positive for V5 expression in various
lines, and the three maximally expressing lines were chosen
for further study. The responses of these three lines were
not different, and data for these lines were combined.
To determine whether Cai was altered in response to a
physiologic reduction in pH, OGR1-transfected CHO cells
were loaded with fura-PE3, and Cai was determined during
continuous perfusion of NTL followed by MET medium.
The initial NTL (pH = 7.37 ± 0.02, PCO2 = 46.6 ± 0.7
mmHg, [HCO3
2] = 26.6 ± 1.6 mM) phase of perfusion
again did not lead to alteration of Cai (Fig. 5A, 0–180 s).
Perfusion with MET (pH = 6.90 ± 0.03, PCO2 = 43.2 ± 1.3
mmHg, [HCO3
2] = 8.2 ± 1.0 mM) led to a rapid increase in
Cai in multiple cells (Fig. 5A, 182–600 s). The increase in
Cai in response to MET was again asynchronous; the in-
crease in Cai in individual cells occurred at various times
after the initial exposure to MET and varied in magnitude
and duration. Pseudocolor representations of selected
ﬁelds among those analyzed for Fig. 5A are shown in Fig.
5B. The ﬁrst frame (B1) indicates the initial time and the
latter three frames show representative responses to acid-
iﬁcation at 250, 280, and 300 s for B2, B3, and B4, respec-
tively. Arrows indicate cells whose relative ﬂuorescence
intensity are shown in the corresponding traces in C1–C4.
The cell indicated in B1 and C1 did not respond to acid.
Cells shown in B2–B4 and corresponding traces C2–C4
illustrate various patterns of response, with some cells
displaying single peaks, whereas others exhibit more
complex responses. The period of time before changes
in Cai were observed after MET reached the perfusion
chamber was shorter than with primary bone cells (com-
pare time to initial peaks in Fig. 5A with Fig. 3B).
Again, changes in Cai were quantiﬁed by two methods:
the distribution of cell number by the peak to nadir ratio
and the percentage of cells with an increase in Cai above
speciﬁc threshold values.
The ratio of the maximum to minimum Cai for each cell
during the initial NTL and MET phases of perfusion was
determined for all 300 time points for each cell and the
distribution of values plotted. Again the distribution of the
peak to nadir ratio for cells during the MET phase of
perfusion was signiﬁcantly different than that for the NTL
phase of perfusion with more cells in MET having a greater
peak to nadir ratio (n = 4758 cells in each group; Fig. 6A)
and the mean value of the ratio (inset) was signiﬁcantly
increased with MET.
The percentage of cells with an increase in Cai above a
speciﬁc threshold (1.1) was determined. A peak in cell Cai
was again deﬁned as a >1.1 increase in area under the curve
of Cai for each time point compared with the mean area
under the curve for the previous ﬁve time points (time
FIG. 4. Quantitation of Cai in primary bone
cells. Changes in Cai were quantiﬁed by two
methods: (A) the distribution of cell number
as a function of the peak to nadir ratio and
(B) the percentage of cells with an increase in
Cai above speciﬁc threshold values. (A) The
ratio of the maximum to minimum Cai for
each cell during the NTL and MET phases of
perfusion was determined and the distribu-
tion of values plotted. The distributions were
signiﬁcantly different, p < 0.01. Inset, mean ±
SE for all NTL and all MET cells. (B) The
percentage of cells with an increase in Cai
above each speciﬁed threshold. The peak in
cell Cai was deﬁned as an increase in Cai of
greater than the speciﬁed threshold (1.1–1.5)
over the mean of the previous ﬁve time points
(time point taken every 2 s) for that cell. n =
2306 cells individually analyzed for A and B;
*p < 0.05.
ACIDOSIS INCREASES INTRACELLULAR CA THROUGH OGR1 309point taken every 2 s) for that cell. This calculation was
repeated for threshold values of 1.2, 1.3, 1.4, and 1.5.
Compared with the initial NTL phase of imaging, there was
a signiﬁcant increase in the percentage of cells with Cai
peaks >1.1, >1.2, >1.3, >1.4, and >1.5 in the MET phase of
imaging (n = 4758 cells individually analyzed; Fig. 6B).
DISCUSSION
An acidic extracellular pH increases osteoclastic bone
resorption through an increase in osteoblastic COX-2,
(10)
leading to an increase in RANKL
(9,13) and subsequent in-
crease in net Ca efﬂux from bone.
(7–10) A class of H
+-
sensing G protein–coupled receptors, whose activity is
mediated by release of the second messengers Cai or
cAMP, has now been identiﬁed.
(18) Stimulation of these H
+
receptors is an attractive mechanism by which bone cells
could sense and initiate the response to acidosis. In this
study, we conﬁrmed the expression of each of four known
proton receptors OGR1, TDAG8, GPR4, and G2A by RT-
PCR of RNA from primary bone cells (Fig. 1).
Because CuCl2 binds to essential histidine residues in
OGR1,
(19) wenext showed that this compound signiﬁcantly
decreased acid-induced bone net Ca efﬂux, a marker of
bone resorption, in cultured neonatal mouse calvariae. To
our knowledge, the speciﬁcity of CuCl2 for proton recep-
tors other than OGR1 has not be reported. The four his-
tidine residues in OGR1 determined by Ludwig et al.
(19) to
be essential for acid induction of inositol phosphate forma-
tion are conserved in GPR4. On the basis of primary
structure, the positioning of histidine residues in TDAG8
and G2A differs from OGR1. These structural features
suggestthatGPR4 mightalso be sensitive toCuCl2, whereas
TDAG8 and G2A would be less susceptible; however, such
predictions would require experimental testing.
The observed suppression of Ca release by CuCl2 in
neutral conditions may indicate that OGR1 or similar re-
ceptors also have a role in establishing the basal rate of
FIG. 5. Imaging of Cai in OGR1-trans-
fected CHO cells. CHO cells transfected with
mouse OGR1 on coverslips were loaded with
fura-PE3 and perfused with physiologically
neutral (NTL) or acid (MET) medium. Cai
levels were determined from ﬂuorescent
emissions at 510 nm after excitation at 340
and 380 nm using a dual wavelength excita-
tionsystem. (A) Perfusion with NTL (0–180 s)
followed byMET (182–600s). Arrow,time of
chamber acidiﬁcation. Relative ﬂuorescence
as a function of time for all cells is shown in B
(n = 255 individual cells). (B) Pseudocolor
images of relative ﬂuorescence intensity; B1,
time = 0; B2, time = 250 s; B3, time = 280 s;
B4, time = 300 s Arrows indicate selected
cells whose change in ﬂuorescence as a func-
tion of time is shown in C1–C4, respectively.
FIG. 6. Quantitation of Cai in OGR1-transfected CHO cells.
Changes in Cai were quantiﬁed by two methods: (A) the distri-
bution of cell number as a function of the peak to nadir ratio and
(B) the percentage of cells with an increase in Cai above speciﬁc
threshold values. (A) The ratio of the maximum to minimum Cai
for each cell during the NTL and MET phases of perfusion was
determined and the distribution of values plotted. The distribu-
tions were signiﬁcantly different, p < 0.01. Inset, mean ± SE for all
NTL and all MET cells. (B) The percentage of cells with an in-
crease in Cai above each speciﬁed threshold. The peak in cell Cai
was deﬁned as an increase in Cai of greater than the speciﬁed
threshold (1.1–1.5) over the mean of the previous ﬁve time points
(time point taken every 2 s) for that cell (n = 4758 cells individually
analyzed for A and B; *p < 0.05).
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Fig. 5 is 4/Cresorption. OGR1 has been previously detected in osteo-
blasts
(19) and is coupled to phospholipase C and increases
in diacylglycerol and inositol phosphate (IP) metabolism,
leading to an increase in Cai.
(19,31) We found that a subset
of cultured primary calvarial cells respond to acidosis pH
with an increase in Cai. To further support OGR1 as a
prime candidate as an osteoblastic H
+ sensor, we asked
whether heterologous cells transfected with OGR1 would
mount a similar Cai response to acidosis as do primary
bone cells. CHO cells were stably transfected with mouse
OGR1 cDNA. When cultures of these transfectants were
perfused with acidic medium, there was a prompt increase
in Cai that was not present in nontransfected CHO cells.
These data indicate that OGR1 is capable of transducing
an increase in Cai in response to MET and is a prime
candidate as the osteoblast proton sensor.
To replicate, to the extent possible, physiologic condi-
tions, in this study, only the HCO3
2/CO2 buffer system was
used to adjust [H
+]; medium pH was adjusted by varying
the [HCO3
2] while maintaining a constant physiologic
PCO2. The open chamber used in the perfusion experi-
ments permits adequate ﬂuid ﬂow while limiting ﬂuid shear
stress, which has been shown to alter Cai.
(32–34) We did not
observe signiﬁcant changes in Cai during perfusion with
neutral pH medium, indicating that there was no response
to either ﬂow or the neutral pH medium (Fig. 3A).
With primary bone cells, the time from when the cells
were acidiﬁed to their maximal increase in Cai and the
magnitude of that increase were heterogenous among the
cells. Not every cell in the ﬁeld showed a measurable in-
crease in Cai to acidosis. By visual examination, the re-
sponding cells were morphologically indistinguishable from
cells that did not respond. It is not clear why some cells
responded to an increase in [H
+] and others did not.
Whereas the primary bonecells used inthisstudy arealmost
exclusively osteoblasts,
(24) they are clearly a heterogenous
population at different levels of maturation.
(35–37) The
ability of the cells to respond to acidosis with increased Cai
may be related to their level of maturation. While the use of
more acidic medium (greater [H
+]) might have elicited a
morerobustresponse,wechosetouseaperfusionpHwithin
the pathophysiologic range (i.e., conditions that are com-
patible with life).
(38–40) With the OGR1-transfected CHO
cells, cell-to-cell variations in the Cai response to H
+ may be
the result of differences in expression of OGR1.
This study does not exclude that other G protein–coupled
H
+ sensors are involved in the response of bone to acidosis.
The function of G2A as an H
+ receptor is controversial and
may be related to speciﬁc cell type,
(30) although its activation
wo u l da ls ole a dtoa nin cr e a sei nCa i.However,thereseemed
to be little expression of G2A in cultured bone cells (Fig. 1).
In contrast, although apparently abundant in cultured bone
cells, TDAG8 and GPR4 are coupled to adenylate cyclase
andshouldnotdirectlyalterCai.
(19–21) Furtherstudies will be
needed to elucidate the potential roles, if any, of other
proton receptors such as TDAG8 and GPR4, whose effect is
mediated through cAMP in the response of bone to acid.
Other proteins that modulate biological responses to
changes in extracellular [H
+] include the pH-sensitive leak
K
+ channel TASK,
(16,17) the vanilloid receptor TRPV1,
(15)
and the proton-gated, voltage-insensitive sodium channels,
the ASICs.
(14) Expression of TASK and TRPV1 by osteo-
blasts has not been reported, although osteoclasts express
TRPV1.
(41) Human pre-osteoblasts express ASIC 1–4 and
retain expression during mineralization.
(42) Whereas the
ASICs are responsive topHincrements inthe range of0.05–
0.06 units,
(43) their pH of half-maximal activation ranges
from 6.5to4.4.
(44) In the experimentsreportedhere, pH was
reduced from 7.4 to 6.9, well above the region of maximal
responsiveness. However, with ASIC3, signiﬁcant changes
in current can be induced by reducing the bath pH from 8.0
to 7.0,
(45) and it is possible that the pH range of the ASICs
could be modulated by accessory proteins. Thus, we cannot
exclude a role for ASICs in acid-induced bone resorption.
In this study we chose to focus on acid-induced changes
in Cai. In addition to its effects on inositol phosphate and
Cai, OGR1 in human aortic smooth muscle cells
(46) or
expressed in CHO or COS7 cells
(31) also activates cAMP
formation. However, the response to H
+, as a function of
the magnitude of the acidosis, is quite different for cAMP.
Whereas IP accumulation is half-maximal at pH ; 7.1, the
cAMP effect is half-maximal at pH ; 6.6, which is well
outside the pH range generally thought to be compatible
with life. We cannot, without further study, exclude a small
contribution of increased cAMP to the OGR1-mediated
increase in Cai shown in this study to acid-induced bone
resorption. We have never found any measurable change in
cAMP in response to MET in either intact calvariae or
primary calvarial cells (unpublished data). A recent pub-
lication has studied acid induction of COX-2 in the human
osteoblastic cell line NHOst.
(47) These cells express OGR1
as the sole G protein–coupled proton–sensing receptor. A
reduction of the incubation pH to 6.7 caused a substantial
increase in Cai, which was sensitive to the Gaq/11 inhibitor
YM-254890. Acid induction of Cai was also inhibited by an
siRNA directed against OGR1.
OGR1 may have roles in multiple bone cell types. The
primary cells used in this study are almost exclusively os-
teoblasts, and our results support the role of OGR1 in the
osteoblastic response to acidosis. However, the importance
of OGR1 in osteoclastogenesis has also been established.
A decrease in medium pH from 7.4 to 7.0 induces Cai
transients in rat osteoclasts, and these transients are sup-
pressed by the phospholipase C inhibitor U73122.
(48) In its
proliferative state, the monocytic cell line RAW264.7 ex-
presses low levels of OGR1 and acidiﬁcation causes only
a minor change in Cai. Osteoclastic differentiation of
RAW264.7 with RANKL increases OGR1 levels and the
Cai response to acidiﬁcation. A short hairpin RNA con-
struct directed against OGR1 decreased the Cai response
to acidiﬁcation in transfected RAW264.7 cells.
(49) Whereas
acidiﬁcation of osteoclastic cells stimulates NFATc1 trans-
location to the nucleus,
(48) acidiﬁcation also promotes
osteoclast survival through a Ca- and ERK-dependent
pathway that is NFAT independent.
(49)
The expression of mouse OGR1 in CHO cells models the
acid-induced increase in Cai in primary bone cells, sug-
gesting that OGR1 acts as the primary mediator of the
response of osteoblasts to increased proton concentration.
The data presented in this study and that of Tomura
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(47) are consistent with a model in which proton acti-
vation of OGR1 leads to increased Cai levels. This increase
acts as a second messenger to mediate the effects of aci-
dosis on osteoblasts, including increased COX-2
(10) and
RANKL
(9,13) expression, which result in increased osteo-
clastic bone resorption.
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